Koninklijke Ahold Delhaize N.V.:企業の戦略・SWOT・財務情報

◆英語タイトル:Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4513
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:小売り
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Koninklijke Ahold Delhaize N.V. – Strategy, SWOT and Corporate Finance Report
Summary

Koninklijke Ahold Delhaize N.V. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Koninklijke Ahold Delhaize N.V. (Ahold Delhaize ) is an international retailing group. The group offers a wide range of perishable and non-perishable food and non-food products that include fruits, vegetables, groceries, drugs, produce and meat, baby products, wine and liquor, and beauty and health care products. Ahold Delhaize serves needs of its customers through several store formats such as supermarkets, superstores, hypermarkets, convenience stores, drugstores, wine and liquor stores, and compact hypers and supermarkets, which are operated under the Food Lion, Hannaford, Stop & Shop, Giant, Martin’s, Albert Heijn, Tempo and Delhaize among other brands. Ahold Delhaize’s operations are spread across the US and Europe. It is headquartered in Zaandam, the Netherlands.

Scope

- Detailed information on Koninklijke Ahold Delhaize N.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Koninklijke Ahold Delhaize N.V. in the form of a SWOT analysis
- An in-depth view of the business model of Koninklijke Ahold Delhaize N.V. including a breakdown and examination of key business segments
- Intelligence on Koninklijke Ahold Delhaize N.V.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Koninklijke Ahold Delhaize N.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Koninklijke Ahold Delhaize N.V. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Koninklijke Ahold Delhaize N.V. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Koninklijke Ahold Delhaize N.V.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Koninklijke Ahold Delhaize N.V.: Company Overview 9
Koninklijke Ahold Delhaize N.V.: Overview and Key Facts 9
Koninklijke Ahold Delhaize N.V.: Overview 9
Koninklijke Ahold Delhaize N.V.: Key Facts 9
Koninklijke Ahold Delhaize N.V.: Key Employees 10
Koninklijke Ahold Delhaize N.V.: Key Employee Biographies 11
Koninklijke Ahold Delhaize N.V.: Major Products and Services 16
Koninklijke Ahold Delhaize N.V.: Company History 18
Koninklijke Ahold Delhaize N.V.: Management Statement 19
Koninklijke Ahold Delhaize N.V.: Key Competitors 24
Koninklijke Ahold Delhaize N.V.: Company Analysis 25
Koninklijke Ahold Delhaize N.V.: Business Description 25
Koninklijke Ahold Delhaize N.V.: SWOT Analysis 26
Koninklijke Ahold Delhaize N.V.: SWOT Overview 26
Koninklijke Ahold Delhaize N.V.: Strengths 26
Koninklijke Ahold Delhaize N.V.: Weaknesses 27
Koninklijke Ahold Delhaize N.V.: Opportunities 27
Koninklijke Ahold Delhaize N.V.: Threats 28
Koninklijke Ahold Delhaize N.V.: Corporate Financial Deals Activity 30
Koninklijke Ahold Delhaize N.V.: Financial Deals Overview 30
Koninklijke Ahold Delhaize N.V.: Targets and Partners 32
Koninklijke Ahold Delhaize N.V.: Top Deals 2014 – 2018YTD* 33
Koninklijke Ahold Delhaize N.V.: Advisors 35
Koninklijke Ahold Delhaize N.V.: Top Financial Advisors 35
Koninklijke Ahold Delhaize N.V.: Mergers and Acquisitions 36
Koninklijke Ahold Delhaize N.V.: Capital Raising 37
Koninklijke Ahold Delhaize N.V.: Divestments 38
Koninklijke Ahold Delhaize N.V.: Recent Developments 39
Koninklijke Ahold Delhaize N.V.: News and Events Summary 39
Koninklijke Ahold Delhaize N.V.: Business Expansion 42
Koninklijke Ahold Delhaize N.V.: Corporate Governance 42
Koninklijke Ahold Delhaize N.V.: Financial Performance 43
Koninklijke Ahold Delhaize N.V.: Market Developments 43
Koninklijke Ahold Delhaize N.V.: Red Flags/DistressSignals 44
Koninklijke Ahold Delhaize N.V.: Research & Development 44
Koninklijke Ahold Delhaize N.V.: Strategy and Operations 44
Appendix 46
Contact Us 46
Methodology 46
About MarketLine 47

List of Tables
Table 1: Koninklijke Ahold Delhaize N.V.: Key Facts
Table 2: Koninklijke Ahold Delhaize N.V.: Key Employees
Table 3: Koninklijke Ahold Delhaize N.V.: Key Competitors
Table 4: Koninklijke Ahold Delhaize N.V.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Koninklijke Ahold Delhaize N.V.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Koninklijke Ahold Delhaize N.V.: M&A Average Deal Size - Value (US$m)
Table 7: Koninklijke Ahold Delhaize N.V.: Targets and Partners
Table 8: Koninklijke Ahold Delhaize N.V.: Top Deals 2014 - 2018YTD*
Table 9: Koninklijke Ahold Delhaize N.V.: Financial Advisor Ranking by Value (US$m)
Table 10: Koninklijke Ahold Delhaize N.V.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Koninklijke Ahold Delhaize N.V.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 12: Koninklijke Ahold Delhaize N.V.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 13: Koninklijke Ahold Delhaize N.V.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 14: Koninklijke Ahold Delhaize N.V.: News and Events Summary
Table 15: Koninklijke Ahold Delhaize N.V.: Business Expansion
Table 16: Koninklijke Ahold Delhaize N.V.: Corporate Governance
Table 17: Koninklijke Ahold Delhaize N.V.: Financial Performance
Table 18: Koninklijke Ahold Delhaize N.V.: Market Developments
Table 19: Koninklijke Ahold Delhaize N.V.: Red Flags/DistressSignals
Table 20: Koninklijke Ahold Delhaize N.V.: Research & Development
Table 21: Koninklijke Ahold Delhaize N.V.: Strategy and Operations

List of Figures
Figure 1: Koninklijke Ahold Delhaize N.V.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Koninklijke Ahold Delhaize N.V.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Koninklijke Ahold Delhaize N.V.: M&A Average Deal Size - Value (US$m)
Figure 4: Koninklijke Ahold Delhaize N.V.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Koninklijke Ahold Delhaize N.V.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: Koninklijke Ahold Delhaize N.V.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: Koninklijke Ahold Delhaize N.V.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Koninklijke Ahold Delhaize N.V.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ind-Swift Laboratories Ltd (INDSWFTLAB):企業の財務・戦略的SWOT分析
    Summary Ind-Swift Laboratories Ltd (ISLL) is a manufacturer of active pharmaceutical ingredients and custom chemical products. Its products portfolio includes API’s and finished dosage forms in the therapeutic categories of macrolide antibiotic, antidiabetic, antimigraine, parkinson's disease, antin …
  • Ocular Therapeutix Inc (OCUL):企業の製品パイプライン分析2018
    Summary Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The company’s products include DEXTENZA, sustained release travoprost and posterior …
  • Sawai Pharmaceutical Co Ltd (4555):製薬・医療:M&Aディール及び事業提携情報
    Summary Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company's products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. It provides products in the form o …
  • P.T. Telekomunikasi Selular:企業の戦略・SWOT・財務情報
    P.T. Telekomunikasi Selular - Strategy, SWOT and Corporate Finance Report Summary P.T. Telekomunikasi Selular - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Anadolubank A.S.:企業の戦略・SWOT・財務情報
    Anadolubank A.S. - Strategy, SWOT and Corporate Finance Report Summary Anadolubank A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Solent NHS Trust:企業の戦略的SWOT分析
    Solent NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • United Therapeutics Corporation:企業の戦略・SWOT・財務情報
    United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report Summary United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Laborie Medical Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Laborie Medical Technologies Inc (Laborie), a subsidiary of Patricia Industries AB, develops and manufactures medical diagnostics and devices. The company offers uroflowmetry, urodynamics, pelvic floor rehabilitation and anorectal manometry products and related consumables. It also provides …
  • Aju Pharm Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Aju Pharm Co Ltd (Aju Pharm) is a pharma and medical device company. The company operates in the business such as pharmaceutical, CMO, medical device, global business and consumer health business. Its pharmaceutical business provides drugs for hypertension, antibiotics, and anti-inflammatory …
  • 01 Communique (ONE):企業の財務・戦略的SWOT分析
    Summary 01 Communique (Communique) is a technology company that develops and delivers integrated communication software and services. The company's products include I'm InTouch meeting, I'm InTouch, I'm OnCall and Communicate!. Communique I'm InTouch provides a secure and easy to use PC remote acces …
  • Invenergy LLC-エネルギー分野:企業M&A・提携分析
    Summary Invenergy LLC (Invenergy) is a full-service energy solutions provider. It invests, develops, constructs, owns, and operates renewable and other clean energy generation and storage facilities. The company captures, generates, and stores power from wind, solar, natural gas, and energy storage …
  • Sojitz Corporation:企業の戦略・SWOT・財務情報
    Sojitz Corporation - Strategy, SWOT and Corporate Finance Report Summary Sojitz Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pharmaceutics International Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmaceutics International Inc (PII) is a contract development and manufacturing organization that offers pharmaceutical product development solutions. The organization offers manufacturing of solid, semi-solid, liquid, inhalation, parenteral and aseptic filling drugs. Its services comprise …
  • Newfield Exploration Company:企業のM&A・事業提携・投資動向
    Newfield Exploration Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Newfield Exploration Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Energias de Portugal SA (EDP):電力:M&Aディール及び事業提携情報
    Summary Energias de Portugal, S.A. (EDP) is a vertically integrated power and gas utility that generates, transmits, distributes and sells electricity; and transports, distributes and sells natural gas. It produces electricity through a diversified portfolio of generation assets including wind, sola …
  • Isofol Medical AB (ISOFOL):製薬・医療:M&Aディール及び事業提携情報
    Summary Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company that develops folate-based therapies for the treatment of cancer patients. The company offers clinical lead candidate Modufolin, a novel folate-based therapy, which is developed to increase the efficacy and reduce the side …
  • The Taiko Bank Ltd:企業の戦略・SWOT・財務情報
    The Taiko Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Taiko Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • BayWa AG:戦略・SWOT・企業財務分析
    BayWa AG - Strategy, SWOT and Corporate Finance Report Summary BayWa AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Ra Pharmaceuticals Inc (RARX):医療機器:M&Aディール及び事業提携情報
    Summary Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals develops its pipeline products through its proprietary peptide …
  • Weifa ASA (WEIFA)-石油・ガス分野:企業M&A・提携分析
    Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆